| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/13/2009 | US7476720 Rat neurotrophic factor receptor, GFR α-4 |
| 01/13/2009 | US7476688 Cyclic amidine derivatives |
| 01/13/2009 | US7476683 Glycinamide derivatives as raf-kinase inhibitors |
| 01/13/2009 | US7476676 Administering to the mammal an effective amount of a GSK-3 beta (glycogen synthase kinase-3 beta) to promote bone formation and treat bone metabolic diseases such as osteoporosis |
| 01/13/2009 | US7476661 for treating basal cell carcinomas, medulloblastomas, and tumors |
| 01/13/2009 | US7476404 Osteoporosis; vitamin D; Calcium Citrate Malate; Potassium Citrate; Magnesium; Boron and Vitamin K |
| 01/13/2009 | CA2423280C Inhibitors of cyclic guanosine 3', 5'-monophosphates specific phosphodiesterase |
| 01/13/2009 | CA2390631C Carboxamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 01/13/2009 | CA2192071C Putamen ovi |
| 01/09/2009 | CA2593623A1 The applications of kidney secreted bone growth factor and pharmaceutical use of flavonol and flavonol glycosides for stimulating the secretion of kidney secreted bone growth factor |
| 01/08/2009 | WO2009006112A1 Mdl-1 uses |
| 01/08/2009 | WO2009005813A1 Modulators of axl for use in treating bone disorders |
| 01/08/2009 | WO2009005726A1 Antigen binding proteins that bind par-2 |
| 01/08/2009 | WO2009005045A1 Substituted dihydroisoquinoline derivative |
| 01/08/2009 | WO2009004995A1 Method of fixing and expressing physiologically active substance |
| 01/08/2009 | WO2009004971A1 Prophylactic/therapeutic agent for articular rheumatism |
| 01/08/2009 | WO2009004152A2 Use of a composition of oligomers of galacturonic acid as an agent for inhibiting degradation of collagen |
| 01/08/2009 | WO2009003905A2 Prognostic method for the determination of the suitability of biopharmaceutical treatment |
| 01/08/2009 | WO2009003211A1 Treatment of rheumatoid arthritis |
| 01/08/2009 | WO2007118198A8 2-METHYLENE-1α,25-DIHYDROXY-19,21-DINORVITAMIN D3 ANALOGS AND USES THEREOF |
| 01/08/2009 | US20090012270 Ox2 receptor homologs |
| 01/08/2009 | US20090012163 Compositions containing Mg/Zn/F-CaP plus inhibitors of pro-inflammatory cytokines (alpha ketoalkanoic acid compound) for osteoporosis prevention, therapy and treatment of bone diseases |
| 01/08/2009 | US20090012149 Prodrug of an ice inhibitor |
| 01/08/2009 | US20090012122 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012093 Receptor Function Regulator |
| 01/08/2009 | US20090012083 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012078 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/08/2009 | US20090012073 N-aroyl cyclic amines |
| 01/08/2009 | US20090012065 Therapeutic applications of pro-apoptotic benzodiazepines |
| 01/08/2009 | US20090012063 Novel imidazole derivatives |
| 01/08/2009 | US20090012059 Dipeptidyl peptidase inhibitors |
| 01/08/2009 | US20090012053 Use of LXR agonists for the treatment of osteoarthritis |
| 01/08/2009 | US20090012047 Crystalline forms of ibandronate sodium |
| 01/08/2009 | US20090012036 Stable S-adenosyl-L-methionine |
| 01/08/2009 | US20090012026 Association Between the Tdoa Gene and Osteoarthritis |
| 01/08/2009 | US20090012003 Polypeptides homologous to vegf and bmp1 |
| 01/08/2009 | US20090011988 Method for treating cartilage disorders |
| 01/08/2009 | US20090011466 Concatameric immunoadhesion molecule |
| 01/08/2009 | US20090011421 Susceptibility to bone damage |
| 01/08/2009 | US20090010940 Parathyroid Hormone Analogues and Methods of Use |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | US20090010911 Methods and compositions for affecting cyclophilin a regulation of kinases in modulating cellular activities |
| 01/08/2009 | US20090010898 Method for treating a mammal having damaged articular cartilage tissue |
| 01/08/2009 | US20090010887 Method and composition for enhancing anti-angiogenic therapy |
| 01/08/2009 | CA2692320A1 Methods of treating bone disorders with modulators of axl |
| 01/08/2009 | CA2692287A1 Treatment of rheumatoid arthritis |
| 01/08/2009 | CA2691618A1 Mdl-1 uses |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011874A1 Recombinant gelatin in vaccines |
| 01/07/2009 | EP2011870A1 Mutant polypeptide having effector function |
| 01/07/2009 | EP2011800A2 Inhibitors of caspase |
| 01/07/2009 | EP2011507A2 Pharmaceutical composition of nateglinide and another antidiabetic agent |
| 01/07/2009 | EP2010528A2 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling |
| 01/07/2009 | EP2010511A1 Chromen-2-one derivatives |
| 01/07/2009 | EP2010220A2 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them |
| 01/07/2009 | EP2010175A1 Piperidine derivatives useful for treating osteoarthritis and osteoartrosis |
| 01/07/2009 | EP2009992A2 Il-8 receptor antagonists |
| 01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
| 01/07/2009 | EP1406641B1 Krill extracts for prevention and/or treatment of cardiovascular diseases |
| 01/07/2009 | EP1357909B1 Il-8 receptor antagonists |
| 01/07/2009 | EP1218361B1 Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 01/07/2009 | EP1204665B1 Chemokine receptor antagonists and methods of use therefor |
| 01/07/2009 | CN101341171A Therapeutic agent |
| 01/07/2009 | CN101338306A Method for treating cell proliferation hyperthyroidism based on anti-SURVIVIN ribozyme |
| 01/07/2009 | CN101337920A Phenylalanyl pyrrolidine derivates, preparation method and application thereof |
| 01/07/2009 | CN101337871A Indandione compound |
| 01/07/2009 | CN101337067A Compound temperature sensitive type in-situ gel nasal-cavity administration preparation for treating osteoporosis |
| 01/07/2009 | CN101337059A Plaster for treating hyperosteogeny and preparation method thereof |
| 01/07/2009 | CN101337056A External traditional Chinese medicine powder for treating gout |
| 01/07/2009 | CN101337030A Medicine composition for reducing swelling and easing pain, preparation method and use thereof |
| 01/07/2009 | CN101337026A External medicine composition for treating gout |
| 01/07/2009 | CN101337014A Traditional Chinese medicine patch for treating internal and external injury |
| 01/07/2009 | CN101337013A Zhuangyao paste for treating waist spinal cavity total-nerve compression due to hyperosteogeny |
| 01/07/2009 | CN101337003A Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion and sciatica |
| 01/07/2009 | CN101336995A Plaster for treating lumbar intervertebral disc protrusion |
| 01/07/2009 | CN101336993A External tincture for treating wind-dampness arthralgia and urgent sprain and preparation method thereof |
| 01/07/2009 | CN101336972A Qingpeng paste and quality standard and detection method thereof |
| 01/07/2009 | CN101336949A Method for extracting polysaccharide and flavone from Gynura divaricata |
| 01/07/2009 | CN101336877A Skin-care product additive containing refined bamboo vinegar and preparation method thereof |
| 01/07/2009 | CN101336873A Natural petal water and preparation technique thereof |
| 01/07/2009 | CN100448875C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 01/07/2009 | CN100448874C N-aroyl cyclic amines |
| 01/07/2009 | CN100448870C 2-aminoquinoline derivative |
| 01/07/2009 | CN100448475C Dry concentrate of yellow wine and preparation method thereof |
| 01/07/2009 | CN100448467C Bone-setting black plaster |
| 01/07/2009 | CN100448461C Medicine for treating aseptic ischemic caput femoris necrosis |
| 01/07/2009 | CN100448460C Herbal drug composition for cartilage protection |
| 01/07/2009 | CN100448446C Buckthorn extract, its preparing method and use in pharmaceutical process |
| 01/06/2009 | US7473779 e.g. 2-amino-N-(4-{[amino(2-thienyl)methylidene]amino}phenethyl)-5-methoxybenzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 01/06/2009 | US7473771 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 01/06/2009 | US7473762 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 01/06/2009 | US7473425 Remedies for ischemic disease |
| 01/06/2009 | US7473420 Processing adipose tissue to deliver a concentrated amount of stem cells in a closed system so that the stem cells are not exposed to external environment by use of a pre-assembled, linked set of closed, sterile containers and tubing allowing for transfer of tissue and fluid elements within a closed path |
| 01/06/2009 | CA2478374C N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/06/2009 | CA2421267C Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 01/06/2009 | CA2414095C Novel compounds |
| 01/06/2009 | CA2379086C 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 01/06/2009 | CA2369504C Pyrazole compositions useful as inhibitors of erk |
| 01/06/2009 | CA2349168C Hyaluronic acid gel, method of its production and medical material containing it |
| 01/06/2009 | CA2270185C Method of preparing a poorly crystalline calcium phosphate and methods of its use |